Drug name - Seebri
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8479730 | NOVARTIS | Inhaler device |
Oct, 2028
(6 years from now) | |
| US8182838 | NOVARTIS | Dry powder composition comprising co-jet milled particles for pulmonary inhalation |
Oct, 2028
(6 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 15.6MCG/INH | POWDER;INHALATION | Discontinued |
availability in other generic markets.
Click on the highlighted region to filter.